About
Intellia Therapeutics develops genome editing therapies using CRISPR technology to create potentially curative treatments for severe and rare diseases.
Explore Intellia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.